Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 06, 16:00
Infinity Pharmaceuticals Cash from Operations (TTM): -38.88M for June 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -38.88M |
| March 31, 2023 | -41.47M |
| December 31, 2022 | -42.43M |
| September 30, 2022 | -43.25M |
| June 30, 2022 | -41.71M |
| March 31, 2022 | -40.68M |
| December 31, 2021 | -40.62M |
| September 30, 2021 | -39.41M |
| June 30, 2021 | -39.43M |
| March 31, 2021 | -37.43M |
| December 31, 2020 | -35.74M |
| September 30, 2020 | -36.10M |
| June 30, 2020 | -38.04M |
| March 31, 2020 | -37.63M |
| December 31, 2019 | -41.53M |
| September 30, 2019 | -16.30M |
| June 30, 2019 | -13.47M |
| March 31, 2019 | -11.13M |
| December 31, 2018 | -4.714M |
| September 30, 2018 | -19.86M |
| June 30, 2018 | -23.91M |
| March 31, 2018 | -28.79M |
| December 31, 2017 | -36.71M |
| September 30, 2017 | -58.89M |
| June 30, 2017 | -82.94M |
| Date | Value |
|---|---|
| March 31, 2017 | -119.66M |
| December 31, 2016 | -154.36M |
| September 30, 2016 | -50.62M |
| June 30, 2016 | -50.45M |
| March 31, 2016 | -35.87M |
| December 31, 2015 | -83.65M |
| September 30, 2015 | -213.40M |
| June 30, 2015 | 59.76M |
| March 31, 2015 | 61.61M |
| December 31, 2014 | 117.72M |
| September 30, 2014 | 128.23M |
| June 30, 2014 | -136.40M |
| March 31, 2014 | -132.16M |
| December 31, 2013 | -113.91M |
| September 30, 2013 | -113.52M |
| June 30, 2013 | -117.54M |
| March 31, 2013 | -94.22M |
| December 31, 2012 | -80.14M |
| September 30, 2012 | -52.60M |
| June 30, 2012 | -29.12M |
| March 31, 2012 | -35.18M |
| December 31, 2011 | -33.11M |
| September 30, 2011 | -33.02M |
| June 30, 2011 | -35.17M |
| March 31, 2011 | -32.57M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-43.25M
Minimum
Sep 2022
-13.47M
Maximum
Jun 2019
-36.71M
Average
-39.41M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
| Athersys Inc | -26.36M |
| Merck & Co Inc | 14.76B |
| MEI Pharma Inc | -52.98M |
| Humanigen Inc | -64.32M |
| Bristol-Myers Squibb Co | 13.72B |